Using discrete choice experiments to design interventions for heterogeneous preferences: protocol for a pragmatic randomised controlled trial of a preference-informed, heterogeneity-focused, HIV testing offer for high-risk populations

Jan Ostermann, Bernard Njau, Amy Hobbie, Tara Mtuy, Martha L Masaki, Aisa Shayo, Marco van Zwetselaar, Max Masnick, Brian Flaherty, Derek S Brown, Axel C Mühlbacher, Nathan M Thielman, Jan Ostermann, Bernard Njau, Amy Hobbie, Tara Mtuy, Martha L Masaki, Aisa Shayo, Marco van Zwetselaar, Max Masnick, Brian Flaherty, Derek S Brown, Axel C Mühlbacher, Nathan M Thielman

Abstract

Introduction: Approximately one million undiagnosed persons living with HIV in Southern and Eastern Africa need to test for HIV. Novel approaches are necessary to identify HIV testing options that match the heterogeneous testing preferences of high-risk populations. This pragmatic randomised controlled trial (PRCT) will evaluate the efficacy of a preference-informed, heterogeneity-focused HIV counselling and testing (HCT) offer, for improving rates of HIV testing in two high-risk populations.

Methods and analysis: The study will be conducted in Moshi, Tanzania. The PRCT will randomise 600 female barworkers and 600 male Kilimanjaro mountain porters across three study arms. All participants will receive an HIV testing offer comprised of four preference-informed testing options, including one 'common' option-comprising features that are commonly available in the area and, on average, most preferred among study participants-and three options that are specific to the study arm. Options will be identified using mixed logit and latent class analyses of data from a discrete choice experiment (DCE). Participants in Arm 1 will be offered the common option and three 'targeted' options that are predicted to be more preferred than the common option and combine features widely available in the study area. Participants in Arm 2 will be offered the common option and three 'enhanced' options, which also include HCT features that are not yet widely available in the study area. Participants in Arm 3, an active control arm, will be offered the common option and three predicted 'less preferred' options. The primary outcome will be uptake of HIV testing.

Ethics and dissemination: Ethical approval was obtained from the Duke University Health System IRB, the University of South Carolina IRB, the Ethics Review Committee at Kilimanjaro Christian Medical University College, Tanzania's National Institute for Medical Research, and the Tanzania Food & Drugs Authority (now Tanzania Medicines & Medical Devices Authority). Findings will be published in peer-reviewed journals. The use of rigorous DCE methods for the preference-based design and tailoring of interventions could lead to novel policy options and implementation science approaches.

Trial registration number: NCT02714140.

Keywords: health economics; hiv & aids; public health; statistics & research methods.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Study design. SMS, short messaging system.

References

    1. UNAIDS Unaids data 2019, 2019.. Available:
    1. Sweat M, Gregorich S, Sangiwa G, et al. . Cost-Effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000;356:113–21. 10.1016/S0140-6736(00)02447-8
    1. Thielman NM, Chu HY, Ostermann J, et al. . Cost-Effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in northern Tanzania. Am J Public Health 2006;96:114–9. 10.2105/AJPH.2004.056796
    1. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA 2009;301:2380–2. 10.1001/jama.2009.828
    1. Cohen MS, Chen YQ, McCauley M, et al. . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505. 10.1056/NEJMoa1105243
    1. Fauci AS, Folkers GK, Dieffenbach CW. Hiv-Aids: much accomplished, much to do. Nat Immunol 2013;14:1104–7. 10.1038/ni.2735
    1. UNAIDS 90-90-90. An ambitious treatment target to help end the AIDS epidemic, 2014. Available:
    1. The Lancet Hiv Divergent paths to the end of AIDS. Lancet HIV 2017;4:e375. 10.1016/S2352-3018(17)30157-1
    1. Granich RM, Gilks CF, Dye C, et al. . Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009;373:48–57. 10.1016/S0140-6736(08)61697-9
    1. National AIDS Control Programme MoH Community development, gender, elderly and children. Health sector HIV and AIDS strategic plan, 2017: 2017–22.
    1. Angotti N, Bula A, Gaydosh L, et al. . Increasing the acceptability of HIV counseling and testing with three C’s: convenience, confidentiality and credibility. Soc Sci Med 2009;68:2263–70. 10.1016/j.socscimed.2009.02.041
    1. Negin J, Wariero J, Mutuo P, et al. . Feasibility, acceptability and cost of home-based HIV testing in rural Kenya. Trop Med Int Health 2009;14:849–55. 10.1111/j.1365-3156.2009.02304.x
    1. Sabapathy K, Van den Bergh R, Fidler S, et al. . Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med 2012;9:e1001351. 10.1371/journal.pmed.1001351
    1. Baggaley R, Hensen B, Ajose O, et al. . From caution to urgency: the evolution of HIV testing and counselling in Africa. Bull World Health Organ 2012;90:652–8. 10.2471/BLT.11.100818
    1. Roura M, Watson-Jones D, Kahawita TM, et al. . Provider-initiated testing and counselling programmes in sub-Saharan Africa: a systematic review of their operational implementation. AIDS 2013;27:617–26. 10.1097/QAD.0b013e32835b7048
    1. Topp SM, Chipukuma JM, Chiko MM, et al. . Opt-out provider-initiated HIV testing and counselling in primary care outpatient clinics in Zambia. Bull World Health Organ 2011;89:328–35. 10.2471/BLT.10.084442
    1. Wanyenze R, Kamya M, Liechty CA, et al. . Hiv counseling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav 2006;10:361–7. 10.1007/s10461-005-9035-9
    1. Corbett EL, Marston B, Churchyard GJ, et al. . Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006;367:926–37. 10.1016/S0140-6736(06)68383-9
    1. Houdmont J, Munir F, Grey M. Acceptance of repeat worksite HIV voluntary counselling and testing in a rural South African factory. AIDS Care 2013;25:1199–202. 10.1080/09540121.2013.764388
    1. Ostermann J, Njau B, Mtuy T, et al. . One size does not fit all: HIV testing preferences differ among high-risk groups in northern Tanzania. AIDS Care 2015;27:595–603. 10.1080/09540121.2014.998612
    1. Ostermann J, Njau B, Brown DS, et al. . Heterogeneous HIV testing preferences in an urban setting in Tanzania: results from a discrete choice experiment. PLoS One 2014;9:e92100 10.1371/journal.pone.0092100
    1. Njau B, Ostermann J, Brown D, et al. . Hiv testing preferences in Tanzania: a qualitative exploration of the importance of confidentiality, accessibility, and quality of service. BMC Public Health 2014;14:838. 10.1186/1471-2458-14-838
    1. Mühlbacher A, Johnson FR. Choice experiments to quantify preferences for health and healthcare: state of the practice. Appl Health Econ Health Policy 2016;14:253–66. 10.1007/s40258-016-0232-7
    1. Hensher DA, Rose JM, Greene WH. Applied choice analysis: a primer. Cambridge; New York: Cambridge University Press, 2005.
    1. Louviere JJ, Hensher DA, Swait JD. Stated choice methods: analysis and applications. Cambridge, UK; New York, NY, USA: Cambridge University Press, 2000.
    1. Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care. Dordrect, The Netherlands: Springer, 2008.
    1. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000;320:1530–3. 10.1136/bmj.320.7248.1530
    1. Johnson FR, Ozdemir S, Phillips KA. Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med 2010;70:183–90. 10.1016/j.socscimed.2009.10.021
    1. Indravudh PP, Sibanda EL, d'Elbée M, et al. . 'I will choose when to test, where I want to test': investigating young people's preferences for HIV self-testing in Malawi and Zimbabwe. AIDS 2017;31 Suppl 3:S203–12. 10.1097/QAD.0000000000001516
    1. Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 2002;37:1681–705. 10.1111/1475-6773.01115
    1. Strauss M, George GL, Rhodes BD. Determining preferences related to HIV counselling and testing services among high school learners in KwaZulu-Natal: a discrete choice experiment. AIDS Behav 2018;22:64–76. 10.1007/s10461-016-1602-8
    1. Ostermann J, Njau B, Brown DS, et al. . Heterogeneous HIV testing preferences in an urban setting in Tanzania: results from a discrete choice experiment. PLoS One 2014;9:e92100. 10.1371/journal.pone.0092100
    1. Quaife M, Eakle R, Cabrera Escobar MA, et al. . Divergent preferences for HIV prevention: a discrete choice experiment for multipurpose HIV prevention products in South Africa. Med Decis Making 2018;38:120–33. 10.1177/0272989X17729376
    1. Cameron MP, Newman PA, Roungprakhon S, et al. . The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine. Vaccine 2013;31:3712–7. 10.1016/j.vaccine.2013.05.089
    1. Newman PA, Cameron MP, Roungprakhon S, et al. . Acceptability and preferences for hypothetical rectal microbicides among a community sample of young men who have sex with men and transgender women in Thailand: a discrete choice experiment. AIDS Behav 2016;20:2588–601. 10.1007/s10461-015-1258-9
    1. Terris-Prestholt F, Hanson K, MacPhail C, et al. . How much demand for new HIV prevention technologies can we really expect? results from a discrete choice experiment in South Africa. PLoS One 2013;8:e83193. 10.1371/journal.pone.0083193
    1. Zanolini A, Sikombe K, Sikazwe I, et al. . Understanding preferences for HIV care and treatment in Zambia: evidence from a discrete choice experiment among patients who have been lost to follow-up. PLoS Med 2018;15:e1002636. 10.1371/journal.pmed.1002636
    1. Kruk ME, Riley PL, Palma AM, et al. . How can the health system retain women in HIV treatment for a lifetime? a discrete choice experiment in Ethiopia and Mozambique. PLoS One 2016;11:e0160764. 10.1371/journal.pone.0160764
    1. d'Elbée M, Indravudh PP, Mwenge L, et al. . Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and Zambia. AIDS 2018;32:2043–9. 10.1097/QAD.0000000000001918
    1. Beusterien KM, Dziekan K, Schrader S, et al. . Patient preferences among third agent HIV medications: a US and German perspective. AIDS Care 2007;19:982–8. 10.1080/09540120701294278
    1. Brégigeon-Ronot S, Cheret A, Cabié A, et al. . Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France. Patient Prefer Adherence 2017;11:1159–69. 10.2147/PPA.S130276
    1. Hauber AB, Mohamed AF, Watson ME, et al. . Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments. AIDS Patient Care STDS 2009;23:29–34. 10.1089/apc.2008.0064
    1. Mühlbacher AC, Stoll M, Mahlich J, et al. . Patient preferences for HIV/AIDS therapy - a discrete choice experiment. Health Econ Rev 2013;3:14. 10.1186/2191-1991-3-14
    1. Ostermann J, Mühlbacher A, Brown DS, et al. . Heterogeneous patient preferences for modern antiretroviral therapy: results of a discrete choice experiment. Value Health 2020;23:851–61. 10.1016/j.jval.2020.03.007
    1. United Republic of Tanzania, National Bureau of Statistics 2012 Tanzania population and housing census, 2012. Available:
    1. Ostermann J, Whetten K, Reddy E, et al. . Treatment retention and care transitions during and after the scale-up of HIV care and treatment in northern Tanzania. AIDS Care 2014;26:1352–8. 10.1080/09540121.2014.882493
    1. Mitchell J, Keane J, Laidlaw J. Making success work for the poor: package tourism in northern Tanzania. Arusha, Tanzania: Overseas Development Institute, SNV Connecting People’s Capacities, 2009.
    1. Peaty D. Kilimanjaro tourism and what it means for local porters and for the local environment. J Ritsumeikan Soc Sci and Humanities 2012;4:1–12.
    1. Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making: a user's guide. Pharmacoeconomics 2008;26:661–77. 10.2165/00019053-200826080-00004
    1. Johnson F, Kanninen B, Bingham M. Experimental design for stated choice studies : BJ K, Valuing environmental amenities using stated choice studies. Dordrecht: Springer, 2007.
    1. Hole AR. Fitting mixed logit models by using maximum simulated likelihood. Stata J 2007;7:388–401. 10.1177/1536867X0700700306
    1. Hensher DA, Rose JM, Greene WH. Applied choice analysis. 2nd edition Cambridge: Cambridge University Press, 2015.
    1. Zhou M, Bridges JFP. Explore preference heterogeneity for treatment among people with type 2 diabetes: a comparison of random-parameters and latent-class estimation techniques. J Choice Model 2019;30:38–49. 10.1016/j.jocm.2018.11.002
    1. Ostermann J, Vasudevan L, Van Zwetselaar M. Mobile phone assisted reminder and incentive system (mParis). integrating mHealthreminders and conditional cash transfers to improve the timeliness of vaccinations inTanzania. poster presented at 2018 NIH mHealth technology showcase for health research. Washington, DC, 2018.
    1. Ostermann J, Vasudevan L, Baumgartner JN, et al. . Do mobile phone-based reminders and conditional financial transfers improve the timeliness of childhood vaccinations in Tanzania? study protocol for a quasi-randomized controlled trial. Trials 2019;20:397. 10.1186/s13063-019-3430-4
    1. Ostermann J, Brown DS, Mühlbacher A, et al. . Would you test for 5000 Shillings? HIV risk and willingness to accept HIV testing in Tanzania. Health Econ Rev 2015;5:60. 10.1186/s13561-015-0060-8
    1. Ministry of Health Community Development Gender Elderly and Children Ministry of health community development gender elderly and children. National AIDS control programme, 2017. Available:
    1. Welfare MoHaS, Tanzania TURo, NACP . National comprehensive guidelines for HIV Testingand counseling. Dar es Salaam, 2013.
    1. Yang J-C, Johnson FR, Kilambi V, et al. . Sample size and utility-difference precision in discrete-choice experiments: a meta-simulation approach. Journal of Choice Modelling 2015;16:50–7. 10.1016/j.jocm.2015.09.001
    1. Orme B. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd Madison, Wisconsin: Research Publishers LLC, 2010.
    1. Zwarenstein M, Treweek S, Gagnier JJ, et al. . Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390. 10.1136/bmj.a2390
    1. National Bureau of Statistics, (OCGS) OotCGS National population projections, 2018. Available:
    1. Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) [Tanzania Mainland], Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), ICF, TANZANIA Malaria Indicator Survey 2017, 2017. Available:

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다